<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> is a condition in which a metaplastic columnar mucosa replaces the <z:mpath ids='MPATH_458'>normal</z:mpath> squamous epithelium of the lower oesophagus </plain></SENT>
<SENT sid="1" pm="."><plain><z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> develops as a complication of <z:e sem="disease" ids="C0017168" disease_type="Disease or Syndrome" abbrv="GERD">gastro-oesophageal reflux</z:e> and predisposes to the development of oesophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>Most <z:mp ids='MP_0009308'>adenocarcinomas</z:mp> arising in Barrett's mucosa are far advanced at the time of diagnosis, and prognosis is consequently poor </plain></SENT>
<SENT sid="3" pm="."><plain>Regular endoscopic surveillance of patients with <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> is recommended to detect the oesophageal <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> in an early presymptomatic stage </plain></SENT>
<SENT sid="4" pm="."><plain>The concept of screening is based on the notion that regular surveillance can reduce the mortality, but there is yet little evidence that this is the case in <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>Screening is generally carried out by regular endoscopy with multiple biopsies in an attempt to detect <z:mpath ids='MPATH_589'>dysplasia</z:mpath> </plain></SENT>
<SENT sid="6" pm="."><plain>Unfortunately, <z:mpath ids='MPATH_589'>dysplasia</z:mpath> is not an ideal biomarker of malignant potential in <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>There is an interest in research into more sensitive and effective predictors of heightened risk for development of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>DNA content flow cytometry and p53 protein expression might be useful in managing the <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> risk in Barrett's patients </plain></SENT>
<SENT sid="9" pm="."><plain>However these new techniques need further evaluation before they can be applied to routine clinical investigation </plain></SENT>
</text></document>